SavedAdd your journal

Journals / Bozok Tıp Dergisi / 2013 / Cilt: 3 - Sayı: 3

Clinical Approach to Patients with Supraventriculer Tachycardia

SUPRAVENRİKÜLER TAŞİKARDİSİ OLAN HASTALARA KLİNİK YAKLAŞIM

Elif BÖREKÇİ
Lütfi AKYOL
Hüseyin EDE
Ali BOLAT
Şafak ŞAHİN
Ali Rıza ERBAY
Savaş SARIKAYA
Yunus Keser YILMAZ
Pages
51–58
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Recently, using of the catheter theraphy is increasing due to high successive and lower complication ratio.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Supraventriculer tachycardia especially is seen in healthy young patients.
📊
Key Findings & Data:Symptoms of patients are changing from mild symptoms including mild palpitation, dyspnea, dizziness to severe symptoms including severe chest pain, dyspnea, congestive heart failure, syncope, deterioration of consciousness.
💡
Conclusion & Impact:Recently, using of the catheter theraphy is increasing due to high successive and lower complication ratio.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Supraventriculer tachycardia especially is seen in healthy young patients. Symptoms of patients are changing from mild symptoms including mild palpitation, dyspnea, dizziness to severe symptoms including severe chest pain, dyspnea, congestive heart failure, syncope, deterioration of consciousness. Treatment and symptoms are depended on the type of supraventriculer tachycardia, duration and numbers of attack of supraventriculer tachycardia and underlying heart disease. The first approach to patient with SVT is to consider whether these patients are stable or have hemodynamic deterioration. Patients with SVT who have hypotension, severe dyspnea, impairing in consciousness should be imme¬diately restored to sinus rhythm with electrocardioversion. In long term management, pharmacological or catheter ablation therapy are applied. Recently, using of the catheter theraphy is increasing due to high successive and lower complication ratio.

Özet

Supraventriküler taşikardi toplumda özellikle genç ve sağlıklı bireylerde gözükmektedir. Hastalarda semptomlar hafif bir çarpıntı hissi, baş dönmesi, göğüs ağrısı ve nefes dar- lığından; ciddi nefes darlığı, göğüs ağrısı, senkop, bilinç bulanıklığını içeren ciddi semp- tomlar arasında değişebilmektedir. Hastalardaki semptomlar ve tedavi supraventriküler taşikardinin tipine, süresine, atak sayısına ve eşlik eden hastalık durumuna göre değişir. Supraventriküler taşikardi ile başvuran hastalara ilk yaklaşım, hastanın başvuru sırasın- da hemodinamik olarak stabil olup olmamasına göre değişir. Bilinç düzeyinde bozulma, hipotansiyon ve ciddi nefes darlığı olan hastalarda acil elektriksel kardiyoversiyon uygu- lanmalıdır. Uzun dönem tedavide ise bu hastalarda farmakolojik veya kateter ablasyon tedavisi uygulanır. Kateter ablasyonu son zamanlarda gittikçe artan, komplikasyon oranı az ve başarı oranı yüksek bir tedavi şekli olarak karşımıza çıkmaktadır.

🔖

Cite This Article

BÖREKÇİ, E., AKYOL, L., EDE, H., BOLAT, A., ŞAHİN, Ş., ERBAY, A. R., SARIKAYA, S., YILMAZ, Y. K. (2022). Clinical Approach to Patients with Supraventriculer Tachycardia. Bozok Tıp Dergisi, Cilt: 3 - Sayı: 3, 51–58. https://ajindex.com/articles/469009

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Orejarena LA, Vidaillet H, Jr., DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998;31(1):150-7
  2. Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004;1(4):393-6
  3. Ko JK, Deal BJ, Strasburger JF, Benson DW. Supraventricular Tachycardia Mechanisms and Their Age Distribution in Pediatric-Patients. Am J Cardiol 1992;69(12):1028-32
  4. Rodriguez LM, de Chillou C, Schlapfer J, Metzger J, Baiyan X, van den Dool A, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol 1992;70(13):1213-5
  5. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation 1993;88(1):282-95. - - r nı k 6. Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med 1995;332(3):162-73
  6. Chauhan VS, Krahn AD, Klein GJ, Skanes AC, Yee R. Supraventricular tachycardia. Med Clin North Am 2001;85(2):193-23. el - - nı r - nı t 8. Mark DG, Brady WJ, Pines JM. Preexcitation syndromes: diagnostic consideration in the ED. Am J Emerg Med 2009;27(7):878-88
  7. Katoh T, Ohara T, Kim EM, Hayakawa H. Non-invasive diagnosis of concealed Wolff- Parkinson-White syndrome by detection of concealed anterograde pre-excitation. Jpn Circ J. 2001;65(5):367-70
  8. Wellens HJ, Brugada P. Mechanisms of supraventricular tachycardia. Am J Cardiol 1988;62(6):10-5
  9. Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia II: management. Pacing Clin Electrophysiol 2006;29(7):769-78
  10. Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006;48(5):1010-7 13. Kastor JA. Multifocal atrial tachycardia. N Engl J Med 1990;322(24):1713-7
  11. Rinkenberger RL, Prystowsky EN, Heger JJ, Troup PJ, Jackman WM, Zipes DP. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 1980;62(5):996-1010
  12. Stewart RB, Bardy GH, Greene HL. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med 1986;104(6):766- 71
  13. Betriu A, Chaitman BR, Bourassa MG, Brevers G, Scholl JM